| Novartis Pharma Schweiz AG - Scemblix 100 mg, Filmtabletten | | 68441 | | 03 | | Scemblix 100 mg | | Filmtabletten | | L01EA06 | | | | 12.05.2025 | | |
| | Composition | | asciminibum 100 mg ut asciminibi hydrochloridum 108.1 mg, lactosum monohydricum 215.55 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), E 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, E 172 (rubrum), E 172 (nigrum), xanthani gummi, pro compresso obducto corresp. natrium max. 2.33 mg. | | Packungsbestandteile | | Filmtabletten | | | | | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | | | Lactose Monohydrat | 215.55 mg | | | Lecithin | | | | | | | | | | | | | | | | Silica Colloidalis Anhydrica | | | | Talcum | | | | | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 120 | PR | PR | A | | Yes |
|
|
